Taken together, our results suggest that RRAGC and/or RRAGD may contribute to mTORC1 signaling in tRCC but are likely not the only mechanism leading to increased mTORC1 activity. Here, RRAGC is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.